[HTML][HTML] Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
P Irún, R Gracia, E Piazuelo, J Pardo, E Morte… - Scientific Reports, 2023 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is highly
heterogeneous, ranging from asymptomatic to severe and fatal cases. COVID-19 has been …
heterogeneous, ranging from asymptomatic to severe and fatal cases. COVID-19 has been …
[HTML][HTML] Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
Coronavirus disease (COVID)-19, as a result of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection, has been the direct cause of over 2.2 million deaths …
Coronavirus 2 (SARS-CoV-2) infection, has been the direct cause of over 2.2 million deaths …
Lipid storm within the lungs of severe COVID-19 patients: Extensive levels of cyclooxygenase and lipoxygenase-derived inflammatory metabolites
ABSTRACT BACKGROUND Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-
2) is the infectious agent responsible for Coronavirus disease 2019 (COVID-19). While …
2) is the infectious agent responsible for Coronavirus disease 2019 (COVID-19). While …
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)
M Ciccarelli, F Merciai, A Carrizzo, E Sommella… - … of Pharmaceutical and …, 2022 - Elsevier
COVID-19 infection evokes various systemic alterations that push patients not only towards
severe acute respiratory syndrome but causes an important metabolic dysregulation with …
severe acute respiratory syndrome but causes an important metabolic dysregulation with …
Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients
H Castañé, S Iftimie, G Baiges-Gaya… - Metabolism, 2022 - Elsevier
Background Lipids are involved in the interaction between viral infection and the host
metabolic and immunological responses. Several studies comparing the lipidome of COVID …
metabolic and immunological responses. Several studies comparing the lipidome of COVID …
[HTML][HTML] Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery
Y López-Hernández, JJ Oropeza-Valdez… - Frontiers in molecular …, 2023 - frontiersin.org
Introduction: Similar to what it has been reported with preceding viral epidemics (such as
MERS, SARS, or influenza), SARS-CoV-2 infection is also affecting the human …
MERS, SARS, or influenza), SARS-CoV-2 infection is also affecting the human …
Phospholipid remodeling and its derivatives are associated with COVID-19 severity
J Wei, X Liu, W Xiao, J Lu, L Guan, Z Fang… - Journal of Allergy and …, 2023 - Elsevier
Background Timely medical intervention in severe cases of coronavirus disease 2019
(COVID-19) and better understanding of the disease's pathogenesis are essential for …
(COVID-19) and better understanding of the disease's pathogenesis are essential for …
[HTML][HTML] Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
M Caterino, M Gelzo, S Sol, R Fedele, A Annunziata… - Scientific reports, 2021 - nature.com
In recent months, Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the world. COVID-19 …
syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the world. COVID-19 …
[HTML][HTML] Link between serum lipid signature and prognostic factors in COVID-19 patients
Although the serum lipidome is markedly affected by COVID-19, two unresolved issues
remain: how the severity of the disease affects the level and the composition of serum lipids …
remain: how the severity of the disease affects the level and the composition of serum lipids …
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
The COVID-19 pandemic ignited research centered around the identification of robust
biomarkers and therapeutic targets. SARS-CoV-2, the virus responsible, hijacks the …
biomarkers and therapeutic targets. SARS-CoV-2, the virus responsible, hijacks the …